Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2023 Jul 17;11(7):e006714corr1. doi: 10.1136/jitc-2023-006714corr1

Correction: Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity

PMCID: PMC10357778  PMID: 37460252

Fernandez-Rodriguez L, Cianciaruso C, Bill R, et al. Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity. J Immunother Cancer 2023;11:e006714. doi: 10.1136/jitc-2023-006714.

This article has been corrected since it was first published. Authors Johannes vom Berg and Sebastian Kobold have now been added to the author list.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES